You just read:

ImmunoCellular Therapeutics Issues Shareholder Letter Providing Update on ICT-107 Program in Newly Diagnosed Glioblastoma

News provided by

ImmunoCellular Therapeutics, Ltd.

Jan 09, 2014, 04:38 EST